The Balance between Persistent Virus Infection and Immune Cells Determines Demyelination

Journal of Immunology

Volumn 157, Issue 12, 1996, Pages 5699-5709

  Rodriguez, Moses ^a   Pavelko, Kevin D ^a   Njenga, M Kariuki ^a   Logan, William C ^a   Wettstein, Peter J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE TRANSFER; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BRAIN; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC DISEASE; DEMYELINATING DISEASE; FEMALE; IMMUNOLOGY; LYMPHOCYTE DEPLETION; MICROBIOLOGY; MOUSE; MOUSE MUTANT; MURINE ENCEPHALOMYELITIS VIRUS; PATHOGENICITY; PATHOLOGY; POLIOMYELITIS; SPINAL CORD; VIRUS LATENCY;

ADOPTIVE TRANSFER; ANIMALS; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; DEMYELINATING DISEASES; FEMALE; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED BALB C; MICE, SCID; POLIOMYELITIS; SPINAL CORD; THEILOVIRUS; VIRUS LATENCY;

EID: 0030589225     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Steinman, L., A. Miller, C. C. Bernard, and J. R. Oksenberg. 1994. The epigenetics of multiple sclerosis: clues to etiology and a rationale for immune therapy. Annu. Rev. Neurosci. 17:247.
2. Ebers, G. C., and A. D. Sadovnick. 1994. The role of genetic factors in multiple sclerosis susceptibility. J. Neuroimmunol. 54:1.
3. Lindsey, J. W., S. Hodgkinson, R. Mehta, O. Mitchel, D. Erizman, and L. Steinman. 1994. Repeated treatment with chimeric anti-CD4 antibody in multiple sclerosis. Ann. Neurol. 36:183.
4. Noseworthy, J. H. 1993. Clinical trials in multiple sclerosis. Curr. Opin. Neurol. Neurosurg. 6:209.
5. The IFNB Multiple Sclerosis Group. 1993. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43:655.
6. Weinstock-Guttman, B., R. M. Ransohoff, R. P. Kinkel, and R. A Rudick. 1995. The interferons: biological effects, mechanisms of action, and use in multiple sclerosis. Ann. Neurol. 37:7.
7. Sibley, W. A., C. R. Bamford, and K. Clark. 1985. Clinical viral infections and multiple sclerosis. Lancet 1:1313.
8. Rodriguez, M., E. Oleszak, and J. Leibowitz. 1987. Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus. Crit. Rev. Immunol. 7:325.
9. Dal Canto, M. C., R. W. Melvold, B. S. Kim, and S. D Miller. 1995. Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection: a pathological and immunological comparison. Microsc. Res. Technol. 32:215.
10. Rodriguez, M. 1992. Central nervous system demyelination and remyelination in multiple sclerosis and viral models of disease. J. Neuroimmunol. 40:255.
11. Rodriguez, M., J. L. Leibowitz, and P. W. Lampert. 1983. Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann. Neurol. 13: 426.
12. Ceredig, R., J. W. Lowenthal, M. Nabholz, and H. R. MacDonald. 1985. Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells. Nature 314:98.
13. Sarmiento, M., A. L. Glasebrook, and F. W. Fitch. 1980. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J. Immunol. 125:2665.
14. Wettstein, P. J., and R. Korngold. 1991. T cell subsets required for the generation of CTL activity directed towards single and multiple histocompatibility antigens. Transplantation 54:206.
15. Janeway, C. A., Jr., P. J. Conrad, E. A. Lemer, J. Babich, P. Wettstein, and D. B. Murphy. 1984. Monoclonal antibodies specific for Ia glycoproteins raised by immunization with activated T cells: possible role of T cellbound Ia antigens as targets of immunoregulatory T cells. J. Immunol. 132:662.
16. Dialynas, D. P., D. B. Wilde, P. Marrack, A. Pierres, K. A. Wall, W. Havran, G. Otten, M. R. Loken, M. Pierres, J. Kappler, and F. W. Fitch. 1983. Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity. Immunol. Rev. 74:29.
17. Pierce, M., and M. Rodriguez. 1989. Erichrome stain for myelin on osmicated tissue embedded in glycol methacrylate plastic. J. Histotechnol. 12:35.
18. Paya, C. V., P. J. Leibson, A. K Patick, and M. Rodriguez. 1990. Inhibition of Theiler's virus-induced demyelination in vivo by tumor necrosis factor alpha. Int. Immunol. 2:909.
19. Rodriguez, M., J. Leibowitz, and C. S. David. 1986. Susceptibility to Theiler's virus-induced demyelination: mapping of the gene within the H-2D region. J. Exp. Med. 163:620.
20. Rodriguez, M., and C. S. David. 1985. Demyelination induced by Theiler's virus: influence of the H-2 haplotype. J. Immunol. 135:2145.
21. Rodriguez, M., C. Nickerson, A. K. Patick, and C. S. David. 1991. Expression of human HLA-B27 transgene alters susceptibility to murine Theiler's virus-induced demyelination. J. Immunol. 146:2596.
22. Kariuki Njenga, M., K. D. Pavelko, J. Baisch, X. Lin, C. David, J. Leibowitz, and M. Rodriguez. 1996. Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice. J. Virol. 70:1729.
23. Ohara, Y., S. Stein, J. L. Fu, L. Stillman, L. Klaman, and R. P. Roos. 1988. Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis viruses. Virology 164:245.
24. Nicholson, S. M., J. D. Peterson, S. D. Miller, K. Wang, M. C. Dal Canto, and R. W. Melvold. 1994. BALB/c substrain differences in susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Neuroimmunol. 52:19.
25. Rodriguez, M., M. D. Lindsley, and M. L. Pierce. 1991. Role of T cells in resistance to Theiler's virus infection. Microb. Pathog. 11:269.
26. Paya, C. V., P. J. Leibson, A. K. Patick, and M. Rodriguez. 1990. Inhibition of Theiler's virus-induced demyelination in vivo by tumor necrosis factor alpha. Int. Immunol. 2:909.
27. Patick, A. K., L. R. Pease, C. S. David, and M. Rodriguez. 1990. Major histocompatibility complex-conferred resistance to Theiler's virus-induced demyelinating disease is inherited as a dominant trait in B10 congenic mice. J. Virol. 64:5570.
28. Rodriguez, M., J. J. Kenny, R. L. Thiemann, and G. E. Woloschak. 1990. Theiler's virus-induced demyelination in mice immunosuppressed with anti-IgM and in mice expressing the xid gene. Microb. Pathog. 8:23.
29. Fujinami, R. S., A. Rosenthal, P. W. Lampert, A. Zurbriggen, and M. Yamada. 1989. Survival of athyrmic (nu/nu] mice after Theiler's murine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibody. J. Virol. 63:2081.
30. Paya, C. V., A. K. Patick, P. J. Leibson, and M. Rodriguez. 1989. Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus. J. Immunol. 143:95.
31. + natural killer cells in C57BL/6 scid mice infected with murine cytomegalovirus. Nat. Immun. 13:239.
32. Bancroft, G. J., and J. P. Kelly. 1994. Macrophage activation and innate resistance to infection in SCID mice. Immunobiology 191:424.
33. Bruce, J., F. W. Symington, T. J. McKearn, and J. Sprent. 1981. A monoclonal antibody discriminating between subsets of T and B cells. J. Immunol. 127:2496.
34. Rodriguez, M., and S. Sriram. 1988. Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 antibody. J. Immunol. 140:2950.
35. Lindsley, M. D., and M. Rodriguez. 1989. Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus. J. Immunol. 142:2677.
36. Gerety, S. J., R. J. Clatch, H. L. Lipton, R. G. Goswami, M. K. Rundell, and S. D. Miller. 1991. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. IV. Identification of an immunodominant T cell determinant on the N-terminal end of the VP2 capsid protein in susceptible SJL/J mice. J. Immunol. 146:2401.
37. + T cell line specific for an immunodominant VP2 epitope. J. Immunol. 152:919.
38. Rodriguez, M., and M. D. Lindsley. 1992. Immunosuppression promotes CNS remyelination in chronic virus-induced demyelinating disease. Neurology 42:348.
39. Welsh, C. J., P. Tonks, A. A. Nash, and W. F. Blakemore. 1987. The effect of L3T4 T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice. J. Gen. Virol. 68:1659.
40. Pullen, L. C., S. D. Miller, M. C. Dal Canto, and B. S. Kim. 1993. Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination. Eur. J. Immunol. 21:2287.
41. Fiette, L., C. Aubert, M. Brahic, and C. P. Rossi. 1993. Theiler's virus infection of beta 2-microglobulin-deficient mice. J. Virol. 67:589.
42. Rodriguez, M., A. J. Dunkel, R. L. Thiemann, J. Leibowitz, M. Zijlstra, and R. Jaenisch. 1993. Abrogation of resistance to Theiler's virus-induced demyelination in H-2b mice deficient in beta 2-microglobulin. J. Immunol. 151:266.
43. Rodriguez, M., L. P. Pease, and C. D. David. 1986. Immune-mediated injury of virus-infected oligodendrocytes: a model of multiple sclerosis. Immunol. Today 7:359.
44. Clatch, R. J., R. W. Melvold, S. D. Miller, and H L. Lipton. 1985. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TEMV-specific delayed-type hypersensitivity. J. Immunol. 135:1408.
45. Rodriguez, M., and C. D. David. 1995. H-2Dd transgene suppresses Theiler's virus-induced demyelination in susceptible strains of mice. J. Neurovirol. 1:111.
46. Azoulay, A., M. Brahic, and J. F. Bureau. 1994. FVB mice transgenic for the H-2Db gene become resistant to persistent infection by Theiler's virus. J. Virol. 68:4049.
47. Lin, X., N. R. Thiemann, L. R. Pease, and M. Rodriguez. 1995. VP1 and VP2 capsid proteins of Theiler's virus are targets of H-2D-restricted cytotoxic lymphocytes in the central nervous system of B10 mice. Virology 214:91.
48. Lindsley, M. D., R. Thiemann, and M. Rodriguez. 1991. Cytotoxic T cells isolated from the central nervous systems of mice infected with Theiler's virus. J. Virol. 65:6612.
49. Fiette, L., C. Aubert, U. Muller, S. Huang, M. Aguet, M. Brahic, and J. F. Bureau. 1995. Theiler's virus infection of 129SV mice that lack the interferon alpha/beta or interferon gamma receptors. J. Exp. Med. 181:2069.
50. Rodriguez, M., K. Pavelko, and R. L. Coffman. 1995. Gamma interferon is critical for resistance to Theiler's virus-induced demyelination. J. Virol. 69:7286.
51. Patick, A. K., L. R. Pease, C. S. David, and M. Rodriguez. 1990. Major histocompatibility complex-conferred resistance to Theiler's virus-induced demyelinaling disease is inherited as a dominant trait in B10 congenic mice. J. Virol. 64:5570.